| Net Cash Provided by (Used in) Operating Activities |
38.9M |
USD |
-91.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-38.9M |
USD |
+89.2% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1B |
shares |
+100% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
511M |
shares |
+31% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
83.2M |
USD |
|
Q1 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
321M |
USD |
-33.2% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
198M |
USD |
+62.8% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
7.67B |
USD |
+29.4% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
461M |
USD |
+9.34% |
Q3 2024 |
Q3 2024 |